Perspectives

Nature Reviews Molecular Cell Biology 6, 891-898 (November 2005) | doi:10.1038/nrm1742

OpinionWhat is the role of protein aggregation in neurodegeneration?

Christopher A. Ross1 & Michelle A. Poirier1  About the authors

Top

Neurodegenerative diseases typically involve deposits of inclusion bodies that contain abnormal aggregated proteins. Therefore, it has been suggested that protein aggregation is pathogenic. However, several lines of evidence indicate that inclusion bodies are not the main cause of toxicity, and probably represent a cellular protective response. Aggregation is a complex multi-step process of protein conformational change and accretion. The early species in this process might be most toxic, perhaps through the exposure of buried moieties such as main chain NH and CO groups that could serve as hydrogen bond donors or acceptors in abnormal interactions with other cellular proteins. This model implies that the pathogenesis of diverse neurodegenerative diseases arises by common mechanisms, and might yield common therapeutic targets.

Author affiliations

  1. Christopher A. Ross and Michelle A. Poirier are in the Division of Neurobiology, Department of Psychiatry at Johns Hopkins University School of Medicine, CMSC 8-121, 600 North Wolfe Street, Baltimore, Maryland 21287, USA.
    Email: caross@jhu.edu
    Email: mpoirie1@jhmi.edu

Published online 15 September 2005

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

SOD1 aggregates in ALS: Cause, correlate or consequence?

Nature Medicine News and Views (01 Dec 1998)

Polyglutamine neurodegeneration: minding your Ps and Qs

Nature Medicine News and Views (01 Jul 2003)

See all 5 matches for News And Views

Extra navigation

Subscribe

Subscribe to Nature Reviews Molecular Cell Biology

Search PubMed for

Open Innovation Challenges

naturejobs

Advertisement